Mapping Alzheimer’s disease progression in 1309 MRI scans: Power estimates for different inter-scan intervals

Neuroimaging centers and pharmaceutical companies are working together to evaluate treatments that might slow the progression of Alzheimer’s disease (AD), a common but devastating late-life neuropathology. Recently, automated brain mapping methods, such as tensor-based morphometry (TBM) of structura...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Hua, Xue, Lee, Suh, Hibar, Derrek P., Yanovsky, Igor, Leow, Alex D., Toga, Arthur W., Jack, Clifford R., Bernstein, Matt A., Reiman, Eric M., Harvey, Danielle J., Kornak, John, Schuff, Norbert, Alexander, Gene E., Weiner, Michael W., Thompson, Paul M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2010
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2846999/
https://ncbi.nlm.nih.gov/pubmed/20139010
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neuroimage.2010.01.104
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi